Background. Serum concentrations of soluble interleukin-2 receptor (IL-2R) were found to be high in patients with autoimmune diseases, lung cancer, malignant lymphoma, tuberculosis, and other diseases. Serum-soluble IL-2R was evaluated as a tumor maker in patients with gastric cancer. Methods. Preo
Serum soluble interleukin 2 receptor levels in patients with breast cancer
β Scribed by Saburo Murakami; Rennzo Hirayama; Akira Satomi; Katsuhiko Okubo; Moriyoki Matsuki; Hideto Sakata; Yoshitaka Tsuji
- Publisher
- Springer Japan
- Year
- 1997
- Tongue
- English
- Weight
- 350 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1340-6868
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Soluble interleukin-2 receptor (sll-2R) levels were quantitated in the seum and synovial fluid (SF) of patients with rheumatoid arthritis (RA) and degenerative joint disease (DJD). A sandwich immunoassay, employing two monoclonal antiodies against distinct epitopes on the lL-2R, was utilized for mea
To investigate whether soluble interleukin-2 receptor (sIL-~R), a marker of T cell activation, could be a useful marker of disease activity in Wegener's granulomatosis (WG). Methods. Soluble IL-2R levels were determined by enzyme-linked immunosorbent assay. WG disease activity in 102 patients was a